Oct 25, 2018
TSO3 to Report Third Quarter 2018 Results on Wednesday, November 7, 2018
Oct 04, 2018
TSO3 Provides a Commercialization Update
Aug 29, 2018
TSO3 Appoints Martin J. Madden to the Board of Directors
Aug 20, 2018
UCHealth performs first patient procedure in Colorado using STERIZONE® technology
Aug 07, 2018
TSO3 Reports Second Quarter 2018 Results
Aug 01, 2018
TSO3 Announces Closing of US$20 million Financing with Courage Capital to Commercialize the STERIZONE® VP4 Sterilizer and Support Getinge Transition
Jul 30, 2018
TSO3 to Report Second Quarter 2018 Results on Wednesday, August 8, 2018
Jun 14, 2018
Altru® Health System Improves Patient Care with Expanded Use of Cutting-Edge Sterilization Technology
May 10, 2018
TSO3 Announces the Vote Results from its Annual Meeting of the Shareholders and the Appointment New Chairperson
May 09, 2018
TSO3 Obtains New Clearance for the STERIZONE® VP4 Sterilizer
May 08, 2018
TSO3 Reports First Quarter 2018 Results
Apr 30, 2018
TSO3 to Report First Quarter 2018 Results and Hold Annual Meeting of Shareholders on Wednesday, May 9, 2018
Apr 26, 2018
TSO3 's Chief Science Officer to moderate Educational Panel at the IAHCSMM Annual Congress
Apr 26, 2018
TSO3 Details Results of Prion Inactivation Studies
Apr 02, 2018
TSO3 Appoints Dr. Douglas Dieter to its Board of Directors
Mar 20, 2018
TSO3 Reports Fourth Quarter and Full Year 2017 Results
Mar 19, 2018
TSO3 Submits Response to US Regulators in Support of Terminal Sterilization of Duodenoscopes
Mar 14, 2018
TSO3's STERIZONE® VP4 Sterilizer Receives 510(k) Clearance for a Significant Enhancement
Mar 07, 2018
TSO3 Sets Fourth Quarter and Full Year 2017 Earnings Call for Wednesday, March 21, 2018 at 8:30 a.m. EDT
Feb 14, 2018
TSO3 to Present at the RBC Capital Markets Healthcare Conference